InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Brady James Aloysius. Officer active across 2 companies, notably Xeris Biopharma Holdings, Inc.. Aggregated, 5 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €52k. History available since 28 March 2025. The latest transaction was filed on 4 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Brady James Aloysius is a declarant linked to Xeris Biopharma Holdings, Inc. and Verona Pharma plc, where he is a Director. The record shows 5 filings in total, and across the 5 recent filings tracked, sales amount to EUR 52387, with a date range from 2025-03-28 to 2026-06-05.